Total submissions: 14
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000170635 | SCV000050787 | benign | not specified | 2013-06-24 | criteria provided, single submitter | research | |
Gene |
RCV000170635 | SCV000223187 | benign | not specified | 2016-09-30 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000170635 | SCV000226119 | benign | not specified | 2015-06-08 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000170635 | SCV000311256 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV000248835 | SCV000317529 | benign | Cardiovascular phenotype | 2012-09-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000248835 | SCV000317648 | benign | Cardiovascular phenotype | 2012-09-17 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000280223 | SCV000470245 | likely benign | Congenital long QT syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000170635 | SCV000538268 | benign | not specified | 2016-04-25 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency in dbSNP (all): 865/2184=40% |
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV000845418 | SCV000987488 | benign | not provided | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV000374712 | SCV001000265 | benign | Long QT syndrome | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000170635 | SCV001361193 | benign | not specified | 2019-08-12 | criteria provided, single submitter | clinical testing | Variant summary: AKAP9 c.4004_4006dupAAC (p.Lys1335_Leu1336insGln) results in an in-frame insertion that is predicted to insert Gln amino acid into the encoded protein. The variant allele was found at a frequency of 0.4 in 281434 control chromosomes, predominantly at a frequency of 0.63 within the African or African-American subpopulation in the gnomAD database, including 4942 homozygotes. Therefore, suggesting the variant is the major allele observed in population(s) of African-American origin. Four ClinVar submissions from clinical diagnostic laboratories (evaluation after 2014) cite the variant three times a benign and once as likely benign. Based on the evidence outlined above, the variant was classified as benign. |
Genome- |
RCV002253258 | SCV002524833 | benign | Long QT syndrome 11 | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000170635 | SCV001922218 | benign | not specified | no assertion criteria provided | clinical testing | ||
Diagnostic Laboratory, |
RCV000170635 | SCV001963017 | benign | not specified | no assertion criteria provided | clinical testing |